Patent details
EP3445786 Title: DIAGNOSIS OF IMMUNE ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR BINDING AGENTS
Basic Information
- Publication number:
- EP3445786
- PCT Application Number:
- FI2017050286
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177224870
- PCT Publication Number:
- WO2017182706
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DIAGNOSIS OF IMMUNE ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR BINDING AGENTS
- French Title of Invention:
- DIAGNOSTIC DE L'ACTIVATION IMMUNITAIRE À L'AIDE D'AGENTS DE LIAISON À CLEVER-1, AU TNF-ALPHA ET À HLA-DR
- German Title of Invention:
- DIAGNOSE VON IMMUNAKTIVIERUNG MIT CLEVER-1-, TNF-ALPHA- UND HLA-DR-BINDUNGSMITTELN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 02/11/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 07/11/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 04/10/2023
- Unitary Effect Registration Date:
- 07/11/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 18/04/2017
- Grant date:
- 04/10/2023
- EP Publication Date:
- 27/02/2019
- PCT Publication Date:
- 26/10/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2023
- EP B1 Publication Date:
- 04/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/04/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/09/2023
- Name:
- Faron Pharmaceuticals OY
- Address:
- Joukahaisenkatu 6, 20520 Turku, Finland (FI)
Inventor
1
- Name:
- VIITALA, Miro
- Address:
- Finland (FI)
2
- Name:
- MAKSIMOW, Mikael
- Address:
- Finland (FI)
3
- Name:
- HOLLMÉN, Maija-Leena
- Address:
- Finland (FI)
4
- Name:
- JALKANEN, Markku
- Address:
- Finland (FI)
Priority
- Priority Number:
- 20165336
- Priority Date:
- 18/04/2016
- Priority Country:
- Finland (FI)
Classification
- IPC classification:
- A61K 39/00; A61P 35/00; A61P 37/04; C07K 16/28; G01N 33/50; G01N 33/68;
Publication
European Patent Bulletin
1
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|